The Evolution of “Partial Breast Irradiation” in Radiation Oncology: A Bibliometric Analysis

Authors

  • Burcu Saglam Alan 1
  1. 1 Department of Radiation Oncology, Antalya Training and Research Hospital, Antalya, Türkiye

Abstract

Background and Aim: Radiation therapy is a cornerstone in the multidisciplinary management of breast cancer, particularly following breast-conserving surgery. Over the past decades, partial breast irradiation (PBI) and accelerated partial breast irradiation (APBI) have emerged as effective alternatives to whole-breast irradiation (WBI) in appropriately selected patients with early-stage breast cancer. This study aimed to perform a comprehensive bibliometric analysis of top-cited publications on PBI to map scientific productivity, influential journals, institutional contributions, and evolving research themes in radiation oncology.

Materials and Methods: A systematic search of the Web of Science Core Collection database was conducted using keywords related to “partial breast irradiation” and “accelerated partial breast irradiation.” The 100 most-cited articles were identified and analyzed with respect to publication year, journal distribution, citation count, citation density, country of origin, leading institutions, authorship patterns, and thematic focus.

Results: The analyzed publications demonstrated a marked growth in scientific interest during the 2000s and 2010s, corresponding to the maturation of randomized controlled trials and consensus guidelines (such as ASTRO and GEC-ESTRO). The United States and European centers led global research output and citation impact, with the International Journal of Radiation Oncology, Biology, Physics and Radiotherapy and Oncology serving as the primary dissemination venues. Research themes evolved from early brachytherapy feasibility studies to external-beam APBI, intraoperative radiotherapy, long-term cosmetic and toxicity outcomes, and patient selection refinement.

Conclusion: Bibliometric mapping of partial breast irradiation highlights the transition of PBI from an investigational technique to an evidence-based standard of care for selected low-risk early-stage breast cancer patients.

Keywords


References

  1. Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-1716.
  2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-1232.
  3. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74(4):987-1001.
  4. Polgár C, Van Limbergen E, Pötter R, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94(3):264-273.
  5. Correa C, Harris EE, Leonardi MC, et al. Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. Pract Radiat Oncol. 2017;7(2):73-79.
  6. Vicini FA, Cecchini RS, White JR, et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019;394(10215):2155-2164.
  7. Whelan TJ, Julian JA, Berrang TS, et al. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet. 2019;394(10215):2165-2172.
  8. Coles CE, Griffin CL, Kirby AM, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017;390(10099):1048-1060.
  9. Meattini I, Marrazzo L, Saieva C, et al. Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial. J Clin Oncol. 2020;38(35):4175-4183.
  10. Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383(9917):603-613.
  11. Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387(10015):229-238.